74results about How to "Rapid and Sensitive Detection" patented technology

The present invention relates to methods and compositions for identifying a pathogen. The inventions provide an antibody-based biosensor probe comprising (AUNT) in combination with a polymer-coated magnetic nanoparticle. In particular, a nanoparticle-based biosensor was developed for detection of Escherichia coli O157:H7 bacterium in food products. Further described are biosensors for detecting pathogens at low concentrations in samples. Even further, a gold nanoparticle-based electrochemical biosensor detection and amplification method for identifying the insertion element gene of Salmonella enterica Serovar Enteritidis is described. The present invention provides compositions and methods for providing a handheld potentiostat system for detecting pathogens outside of the laboratory. The AUNT biosensor system has applications detecting pathogens in food, water, beverages, clinical samples, and environmental samples.

Disclosed are methods and devices for detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection. The inducer molecule is released from the infected bacterium and is detected by genetically modified bacterial bioreporter cells designed to emit bioluminescence upon stimulation by the inducer. Autoamplification of the bioluminescent signal permits detection of low levels of bacteria without sample enrichment. Also disclosed are methods of detection for select bacteria, and kits for detection of select bacteria based on the described technology.

The invention discloses a method and a device for fast detection of aerosol particle concentration and size distribution. The method comprises the following steps of: forming a gas flow containing aerosol particles; enabling the gas flow to pass through at least one corona area so that at least partial aerosol particles to be detected in the gas flow are negatively charged; before the actual field measurement, measuring the length L of the corona area, pipe diameter H and gas flow speed v0, searching or measuring the density d of the particles, conducting a calibration experiment for the aerosol particle gas flow having a determined diameter D, then performing an actual measurement and finally calculating the number n of the particles at each level according to the formula YN=22N-2kD2 (22n-2-21-n) nN, in which YN, k, D are known; multiplying the number n of the particles at each level by a single mass of the particles at each level, and then summing the products to obtain a concentration value of the total particles in the gas flow. By the method provided by the invention, the size distribution proportion and the concentration of the aerosol particles in the air or the pipe gas flow can be detected conveniently, sensitively and quickly.

An improved method allowing for rapid sensitive and standardized detection of a target nucleic acid from a pathogenic microorganism or virus or normal or abnormal gene in a sample is provided. The method involves hybridizing a target nucleic acid to several non-overlapping oligonucleotide probes that hybridize to adjacent regions in the target nucleic acid, the probes being referred to capture/amplification probes and amplifications probes, respectively, in the presence of paramagnetic beads coated with a ligand binding moiety. Through the binding of a ligand attached to one end of the capture/amplification probe and the specific hybridization of portions of the probes to adjacent sequences in the target nucleic acid, a complex comprising the target nucleic acid, the probes and the paramagnetic beads is formed. The probes may then ligated together to form a contiguous ligated amplification sequence bound to the beads, which complex may be denatured to remove the target nucleic acid and unligated probes. Alternatively, separate capture and amplification probes may be used which form continuous full-length or circular probes, and may be directly detected or amplified using a suitable amplification technique, e.g., PCR, RAM or HSAM for detection. The detection of the ligated amplification sequence, either directly or following amplification of the ligated amplification sequence, indicates the presence of the target nucleic acid in a sample. Methods for the detection of the ligated amplification sequence, including hybridization signal amplification method and ramification- extension amplification method, are also provided.

The invention relates to a monoclonal antibody as well as a preparation method and application thereof, in particular to a monoclonal antibody of fluoroquinolone drugs and application thereof, belonging to the technical field of immunochemistry. The monoclonal antibody of fluoroquinolones 4G11' is produced from a mouse hybridoma cell strain 4G11, and the subtype of 4G11 is an IgG1 type. The invention has the advantages that the monoclonal antibody 4G11' produced from the mouse hybridoma cell strain 4G11 has high cross reaction rate with various fluoroquinolone medicines and can be produced in large quantity and used for preparing an enzyme linked immunosorbent assay kit and colloidal gold test paper for detecting the fluoroquinolone medicines, achieves the purpose of quickly and sensitively detecting the residual fluoroquinolone medicines in milk, muscle and aquatic products and provides a basis for developing a kit for detecting various residual fluoroquinolone medicines.

The invention discloses a method for detecting the phthalic acid ester compound concentration based on optical fiber immunosense. The method includes the steps that firstly, an optical fiber immunosense detection system is established; secondly, a standard inhibition curve is established, wherein (2.1), a fluorescently-labeled antibody solution and a phthalic acid ester compound standard solution with the known concentration are mixed, data obtained after pre-reaction are input to the optical fiber immunosense detection system, and a response signal is obtained; (2.2), the concentration of phthalic acid ester compounds is changed, the step of (2.1) is repeated, and response signals under different concentrations are obtained; (2.3) the standard inhibition curve is drawn according to the concentration logarithm value and the inhibition ratio; (3.1), the step of (2.1) is repeated on the phthalic acid ester compounds to be detected, and a response signal and the inhibition ratio are obtained; (3.2) according to the standard inhibition curve, the concentration of the phthalic acid ester compounds to be detected can be obtained. The method can detect various kinds of PAEs at the same time and is high in sensitivity and precision and fast in detection.

The present invention relates to assays and kits for carrying out said assays for the rapid, automated detection of infectious pathogenic agents and normal and abnormal genes. The present invention further relates to methods for general amplification of genomic DNA and total mRNAs and for analyzing differential mRNA expression using the amplification methods disclosed herein.

Disclosed are methods and compositions for detecting variation in nucleic acids. The disclosed method compares the sequence of a nucleic acid of interest with the sequence of a reference nucleic acid to sensitively identify variations between the sequence of a nucleic acid of interest and the sequence of a reference nucleic acid. The disclosed method generally involves excision and replacement of selected nucleotides in nucleic acid strands hybridized to other strands. In the method, if the excised nucleotide was mismatched with the nucleotide in the other, hybridized strand, then the replacement nucleotide will not be mismatched. If the excised nucleotide was not mismatched with the nucleotide in the other, hybridized strand, then the excised nucleotide is not replaced. This difference allows detection of variation in the nucleic acid of interest. In some forms of the method, by replacing excised nucleotides with nuclease-resistant nucleotides, strands in which excised nucleotides are replaced will be resistant to nuclease digestion while strands in which excised nucleotides are not replaced will be sensitive to nuclease digestion. By exposing the hybridizing nucleic acids to nuclease following replacement of excised nucleotides, the strands in which excised nucleotides are not replaced can be destroyed by the nuclease while strands in which excised nucleotides are replaced can be preserved. The remaining strands can then be detected and whether the strand survived nuclease digestion can be noted. Strands that survive nuclease digestion are indicative of the presence of variation in the nucleic acid of interest.

The subject invention provides methods, assays, and products for detecting small-molecule targets in a complex sample in both clinical and field settings. The subject invention provides aptamer-based sensors and methods of use thereof. The subject invention provides exonuclease-based methods for generating structure-switching aptamers from fully folded or pre-folded aptamers and developing aptamer-based sensors for small-molecule detection. The method for detecting one or more small-molecule targets in a sample comprises contacting the sample with one or more aptamer-based sensor selective for each of the small-molecule targets, and detecting the small-molecule target in the sample.

The invention provides a method and device used for measuring carbinol content in alcoholic solutions. The device of the invention is a biological micro-sensor which is used for electrochemical carbinol measurement and based on enzyme reaction, can carry out quick and sensitive detection aiming at the content of the carbinol in real alcohol samples, achieve the effect of saving time and cost, and greatly improve the convenience in use. The method and device of the invention can be directly used for the screening and checking of the false wine, thus achieving the aim of avoiding the generation of false wine poisoning events.

An optical blood detector system is described that rapidly detects the presence of blood due to a blood leak in a system. The blood detector system contains a reusable blood sensor that is able to accurately detect the presence of blood in, for example, an extracorporeal blood treatment system by optically sensing light from a sensing region and determining if the light came from a leaked blood. The blood sensor may be responsive to reflected light or light emitted from blood due to bio-fluorescence excited by a light source in the blood detector system. The blood detector system can be placedagainst absorbent material adjacent to an intravenous needle injection site and quickly detect any blood wicked into the absorbent material. The blood detector system can eliminate the need for medical personnel to continuously inspect numerous patients visually for potentially fatal blood leaks due to needle dislodgement.

The invention relates to a method for detecting adrenaline by a metal-terbium fluorescent probe and use of the method. According to the method, the adrenaline, disodium edetate and a rare-earth element terbium form a stable ternary complex in an alkaline solution, and the ternary complex can emit characteristic fluorescence of Tb(III). Through adding hexadecyltrimethylammonium chloride, which serves as a sensitizing agent, into the ternary complex, the fluorescence intensity of the ternary complex can be remarkably enhanced. The relative fluorescence intensity of the ternary complex is proportional to adrenaline concentration in the adrenaline concentration range of 7.0*10<-8>mol/L to 5.0*10<-5>mol/L, and the detection limit is 2.1*10<-8>mol/L. According to the method, the interference resulting from common metal ions and drug excipients can be eliminated; the method is high in sensitivity, simple in operation and low in detection limit; the result is good when the method is applied to the detection on adrenaline injections.

Methods and cartridges for detecting targets are provided. A biological sample is introduced to a cartridge. Targets in the sample are photonically labeled with fluorescent particles in a first liquid layer in the cassette. Photonically-labeled targets are separated out of the sample into a second liquid layer within the cassette, detected, and counted to show presence of the targets in the subject. Cartridges include a receiving reservoir, a mixing well for introducing the sample to photonic labels and magnetic particles, and an imaging well for detecting and counting targets from the sample. The sample may be a human stool sample. A filter may be used to filter particulates out of the sample.

The invention provides a hybridoma cell strain, an anti-salbutamol monoclonal antibody generated by the hybridoma cell strain and application, and belongs to the technical field of immunochemistry. The invention discloses a hybridoma cell strain 8D7 which generates the anti-salbutamol monoclonal antibody and is stored with a number of CGMCC (China General Microbiological Culture Collection Center) No., 7953, an anti-salbutamol monoclonal antibody 8D7' secreted by the hybridoma cell strain 8D7, and application of the anti-salbutamol monoclonal antibody in preparation of an enzyme linked immunosorbent assay kit and a colloidal gold test strip used for detecting salbutamol. The hybridoma cell strain 8D7 can efficiently and stably secrete the anti-salbutamol monoclonal antibody; the anti-salbutamol monoclonal antibody has high titer, specificity and sensitivity, can be produced as mass, and realizes the effect of quickly and sensitively detecting a salbutamol medicine residual in urine, muscle and viscera. By adopting the anti-salbutamol monoclonal antibody for detecting the salbutamol residual in a sample, toxic agents are not needed during treating the sample, and the operation is simple.